An EU clinic group turned an in-clinic copper-peptide protocol into a private-label retail serum it could actually stand behind

Challenge

The clinic group ran an in-clinic GHK-Cu treatment across several locations in two EU countries and wanted a take-home serum its patients could buy between visits, under the clinic's own name. What it had: a positioning concept, packaging direction, and a loyal patient base. What it lacked: a stable INCI-compliant formula, an EU CPNP notification pathway, and a manufacturer willing to own the chemistry. Building that capability in-house was a roughly year-long detour, and the retail window the marketing team was aiming at was a fraction of that.

Approach

PeptideXpo ran this as a finished-goods OEM engagement against the clinic's brief rather than a raw-material sale — which is the part of our catalog breadth that mattered here. We sourced the GHK-Cu at cosmetic grade from the same supply we already characterize for copper-peptide buyers, developed an aqueous-gel carrier suited to a copper-bound active, ran the formula through the standard accelerated and real-time stability timepoints, aligned the INCI and supporting documentation to EU CPNP expectations, sourced primary packaging to the clinic's brand spec, and handled finished-goods QC release. The clinic kept what it was best at — secondary packaging, the patient relationship, and the storytelling.

Outcome

The serum reached first commercial shipment comfortably inside the marketing window, with weeks of margin rather than a scramble. Early sell-through through the clinics tracked in the healthy band you'd hope for from a first cosmetic-peptide launch with an existing patient audience, and the CPNP notification — filed on the documentation package we supplied — went through without a documentation-driven round-trip. The clinic now treats the line as a repeatable product it can reorder against, not a one-off project.